BRIEF-Ardelyx announces Tenapanor reduces pain caused by IBS-C through inhibition of TRPV-1 signaling By: Reuters: Company News October 16, 2017 at 08:29 AM EDT * Ardelyx announces Tenapanor reduces pain caused by IBS-c through inhibition of TRPV-1 signaling Read More >> Related Stocks: Ardelyx Inc